[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.142.219. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Comment & Response
September 22/29, 2015

Maternal Antidepressant Use and Persistent Pulmonary Hypertension of the Newborn

Author Affiliations
  • 1Department of Child Psychiatry, Athens University Medical School, Athens, Greece
JAMA. 2015;314(12):1293-1294. doi:10.1001/jama.2015.10039

To the Editor In a cohort study, Dr Huybrechts and colleagues1 found that maternal use of selective serotonin reuptake inhibitors (SSRIs) in late pregnancy was associated with a potential increased risk of persistent pulmonary hypertension of the newborn (PPHN). The source cohort was restricted to women with a depression diagnosis, and a logistic regression analysis was used to estimate the odds ratios for PPHN associated with antidepressant exposure. However, the authors decided not to adjust for cesarean delivery because it has been shown that conditioning on such an intermediate perinatal factor is susceptible to overadjustment bias.

First Page Preview View Large
First page PDF preview
First page PDF preview
×